Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian cancers (AOC). Trastuzumab, tested only as a single agent, has been shown to ...
10don MSN
In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine ...
and expression of the HER2 17q12-21 chromosomal amplicon, including the ERBB2 gene. HER2DX ®️ predicts: Risk of relapse score (high vs. low): risk of recurrence in patients with newly diagnosed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback